OSCR Oscar Health, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
16:54
Aug 14
Aug 14
Thrive Capital's Q2 filing shows new positions in SpaceX and Amazon while exiting Carvana.
Thrive Capital's Q2 filing shows new positions in SpaceX and Amazon while exiting Carvana and StubHub, with major holdings in SpaceX, Amazon, Oscar Health, Shopify, and Figma.
21:52
Aug 09
Aug 09
OSCR ahead of 2027 targets a year early
Buy OSCR; the company has already surpassed CEO Bertolini's 2027 revenue target ($15.32B vs. $14B guided) a full year early while approaching his 5% EBIT margin goal at 4.1%, suggesting management guidance is conservative and the stock may re-rate higher.
MED
11:18
Aug 06
Aug 06
Long OSCR after strong results; $50 target.
Long OSCR; author has been long since a November 2025 deep dive, the stock is already up 2x, and strong results mark just the beginning of the move toward $50.
HIGH
10:18
Aug 06
Aug 06
Expects OSCR to fade premarket guidance gains
Author expects OSCR to fade its premarket gains, arguing the raised guidance was already mathematically implied by strong Q1 earnings.
MED
00:37
Jul 14
Jul 14
Author discloses a current long position in OSCR.
Author discloses a current long position in OSCR, indicating personal conviction in the healthcare stock.
MED
19:00
Jul 01
Jul 01
CEO insider purchase of $12M in OSCR shares, now worth $30M.
CEO insider purchase of $12M in OSCR shares, now worth $30M; factual event noted with approving tone.
MED
11:36
Jun 26
Jun 26
Author took partial profits on OSCR near $13 average but retains most shares.
Author took partial profits on OSCR near $13 average but retains most shares, while holding HIMS without selling, reflecting mixed conviction.
18:06
Jun 22
Jun 22
Buy OSCR expecting continued rotation into healthcare from saturated hardware.
Buy OSCR expecting continued rotation into healthcare from saturated hardware; Q1 momentum and upcoming Q2 catalyst support $40 target.
MED
16:53
Jun 09
Jun 09
Rotate from overvalued tech to undervalued healthcare based on record relative valuation.
Rotate from overvalued tech to undervalued healthcare based on record relative valuation disparity; author holds OSCR and UNH and expects further outperformance.
HIGH
02:41
Jun 09
Jun 09
The author's comment that OSCR looks phenomenal is a hot take without an explicit position.
The author's comment that OSCR looks phenomenal is a hot take without an explicit position or forward call, so it is treated as a watch.
LOW
16:32
Jun 08
Jun 08
Watch OSCR: author reacts positively with LFG to a bullish parent view.
Watch OSCR: author reacts positively with LFG to a bullish parent view, but does not disclose an active position or concrete trade in this reply.
LOW
16:20
Jun 08
Jun 08
Author discloses current long position in OSCR alongside LMND.
Author discloses current long position in OSCR alongside LMND, with the shared thesis that tech-driven insurers can disrupt the entrenched, century-old insurance industry.
MED
15:47
Jun 08
Jun 08
Author discloses being up over 100% on their Oscar position after increasing it at $14.19.
Author discloses being up over 100% on their Oscar position after increasing it at $14.19, signaling strong conviction and a bullish outlook.
14:40
Jun 08
Jun 08
Author fully exits large OSCR position
Author fully exits large OSCR position to reallocate capital after a remarkable run from $11 to $26.50.
MED
17:30
Jun 05
Jun 05
Buy OSCR with a $30 price target supported by a bottom-up valuation.
Buy OSCR with a $30 price target supported by a bottom-up valuation: $20B projected revenue at 2.5% net margin implies at least $10B market cap at a 0.5x sales multiple, suggesting meaningful upside from current levels.
MED
15:45
May 12
May 12
Strong Q1 performance significantly decreases overall risk
Notes strong Q1 performance significantly decreased overall risk for the company following a massive recent price rally.
MED
20:04
May 08
May 08
Notes prior ownership and partial share sale
Notes that an unnamed entity owned Oscar shares before the IPO and has since sold some of them.
LOW
02:20
May 07
May 07
OSCR technical setup, 23.79 target watched
Speaker missed long entry at 10.49 into a yearly bullish imbalance on OSCR; now watching tomorrow's open relative to a bearish imbalance level as the key bull/bear trigger, with a technical target of 23.79.
MED
14:26
May 06
May 06
Estimates high probability of exceeding guidance
Analyzes the decision to maintain guidance, estimating a 70-75% probability that full-year guidance will be comfortably exceeded.
MED
11:23
May 06
May 06
Reports massive Q1 earnings beat
Reports a massive Q1 earnings beat driven by low MLR, but notes the blowout quarter does not annualize.
MED
11:22
May 06
May 06
Observes incredible quarter for OSCR
Observes an incredible quarter for OSCR, no directional view from the speaker.
LOW
05:59
Apr 27
Apr 27
Ozark sarcastically suggests OSCR and MOH would be best based on flawed logic.
Ozark sarcastically suggests OSCR and MOH would be best based on flawed logic, noting OSCR already bounced, without a clear directional view.
HIGH
10:49
Apr 21
Apr 21
Significant position held ahead of Q1 results
Author discloses a significant portfolio position, expecting prices above $18 driven by historically strong Q1 results and the invalidation of previous risks.
MED
16:54
Apr 15
Apr 15
The tweet expresses a bullish outlook on Molina Healthcare and Oscar Health.
The tweet expresses a bullish outlook on Molina Healthcare and Oscar Health, indicating positive sentiment towards these managed care and health insurance companies.
20:37
Apr 11
Apr 11
Speaker reviews $OSCR: market cap same as 2021/2023 but 2x revenue, massive scale gains.
Speaker reviews $OSCR: market cap same as 2021/2023 but 2x revenue, massive scale gains, clear path to profitability — undervalued thesis.
MED
00:48
Apr 09
Apr 09
CEO bought OSCR after sharp rally
Reports OSCR up 12.88% and CEO buying 1 million shares at $11.92; insider activity is notable but no personal directional commitment is made.
MED
05:33
Apr 08
Apr 08
CEO buys $12M stock after grace period
Notes a $12M insider purchase by the CEO and the absence of a profit warning following the end of the grace period.
MED
14:06
Apr 06
Apr 06
Lack of 8-K suggests membership meets guidance
Notes OSCR is up 14% as the lack of an 8-K filing suggests membership aligns with guidance.
MED
About OSCR Analyst Coverage
Buzzberg tracks OSCR (Oscar Health, Inc.) across 10 sources. 14 bullish vs 0 bearish calls from 9 analysts. Sentiment: predominantly bullish (13%). 111 total trade ideas tracked. Latest voices: unusual_whales, caesarcapitalz, oguzerkan.